Condition
Congenital Heart Defects clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Congenital Heart Defects clinical trials that are recruiting, at sites in 2 countries (most in France (4), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Congenital Heart Defects clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pulmonary Artery Growth in Tetralogy of Fallot: A Look at Nakata Index Over Time | — | Strasbourg | Recruiting | Oct 7, 2026 |
| Partial versus complete thymus removal during infant heart surgery | — | Nantes and 1 other locations | Recruiting | Jun 13, 2025 |
| Understanding neurodevelopmental disorders in children with congenital heart defects | — | Brest, Brittany Region and 4 other locations | Recruiting | Jun 4, 2024 |
| Creating a DNA bank for congenital heart disease in southeastern France | — | Marseille | Recruiting | Oct 4, 2016 |
| Understanding the genetics of heterotaxy and congenital heart defects | — | Indianapolis, Indiana | Recruiting | May 1, 2015 |
All recruiting trials (5)
-
Pulmonary Artery Growth in Tetralogy of Fallot: A Look at Nakata Index Over Time
This study tests how pulmonary artery sizes change from birth through surgery in kids with Tetralogy of Fallot to see if the Nakata index can help guide treatment.
-
Partial versus complete thymus removal during infant heart surgery
This will test whether removing only part of the thymus instead of the whole gland during heart surgery helps preserve immune function in infants under 6 months.
-
Understanding neurodevelopmental disorders in children with congenital heart defects
This study is trying to see how heart surgery in young children with serious heart defects affects their brain development and behavior as they grow up.
-
Creating a DNA bank for congenital heart disease in southeastern France
This study is creating a DNA bank for people with congenital heart defects in southeastern France to help understand the genetic causes of these conditions better.
-
Understanding the genetics of heterotaxy and congenital heart defects
This study is trying to learn more about the genetics behind heterotaxy syndrome and congenital heart defects by collecting information and samples from affected individuals and their families.
Related topics
Quick answers
How many Congenital Heart Defects clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.